U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 32.95
+0.60 (1.85%)
Jun 18, 2026, 2:51 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 973.67 million as of June 18, 2026. Its market cap has decreased by -20.60% in one year.
Market Cap
973.67M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.95
Market Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 973.67M, a decrease of -28.37%. That is a compound annual growth rate of -10.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 973.67M | -13.06% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.13B |
| LabTurbo Biotech | 1.09B |
| Holy Stone Healthcare | 1.07B |
| Lukas Biomedical | 1.03B |
| Level Biotechnology | 1.02B |
| GeneReach Biotechnology | 999.94M |
| Meribank Biotech | 954.00M |
| Taiwan Advance Bio-Pharmaceutical | 949.50M |